These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22093966)
41. Value of power Doppler sonography with 3D reconstruction in preoperative diagnostics of extraprostatic tumor extension in clinically localized prostate cancer. Zalesky M; Urban M; Smerhovský Z; Zachoval R; Lukes M; Heracek J Int J Urol; 2008 Jan; 15(1):68-75; discussion 75. PubMed ID: 18184177 [TBL] [Abstract][Full Text] [Related]
42. [The value of prostatic biopsy in tumor mapping]. Salomon L; Colombel M; Patard JJ; Lefrére-Belda MA; Bellot J; Gasman D; Hoznek A; Chopin D; Abbou CC Prog Urol; 1998 Apr; 8(2):217-22. PubMed ID: 9615931 [TBL] [Abstract][Full Text] [Related]
43. Sextant-Specific Analysis of Detection and Tumor Volume by HistoScanning™. Porres D; Kuru TH; Epplen R; Eck A; Zugor V; Kennes LN; Afram S; Braunschweig T; Knüchel-Clarke R; Pfister D; Heidenreich A Urol Int; 2016; 96(2):194-201. PubMed ID: 26555799 [TBL] [Abstract][Full Text] [Related]
44. [The use of MRI with a pelvic phased array antenna in the evaluation of the gland and tumor volume of clinically localized prostatic adenocarcinoma]. Tollon C; Soulié M; Aziza R; Escourrou G; Pontonnier F; Plante P Prog Urol; 1998 Apr; 8(2):223-31. PubMed ID: 9615932 [TBL] [Abstract][Full Text] [Related]
45. Comprehensive report on prostate cancer misclassification by 16 currently used low-risk and active surveillance criteria. Palisaar JR; Noldus J; Löppenberg B; von Bodman C; Sommerer F; Eggert T BJU Int; 2012 Sep; 110(6 Pt B):E172-81. PubMed ID: 22314081 [TBL] [Abstract][Full Text] [Related]
46. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839 [TBL] [Abstract][Full Text] [Related]
47. Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: an early experience. Shoji S; Hiraiwa S; Endo J; Hashida K; Tomonaga T; Nakano M; Sugiyama T; Tajiri T; Terachi T; Uchida T Int J Urol; 2015 Feb; 22(2):173-8. PubMed ID: 25316213 [TBL] [Abstract][Full Text] [Related]
48. Contrast-enhanced transrectal ultrasonography: measurement of prostate cancer tumor size and correlation with radical prostatectomy specimens. Qi TY; Chen YQ; Jiang J; Zhu YK; Yao XH; Qi J Int J Urol; 2013 Nov; 20(11):1085-91. PubMed ID: 23551612 [TBL] [Abstract][Full Text] [Related]
49. Prostate biopsy: who, how and when. An update. Djavan B; Milani S; Remzi M Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165 [TBL] [Abstract][Full Text] [Related]
50. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume. Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203 [TBL] [Abstract][Full Text] [Related]
51. Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system. Dickinson L; Hu Y; Ahmed HU; Allen C; Kirkham AP; Emberton M; Barratt D BJU Int; 2013 Sep; 112(5):594-601. PubMed ID: 23819525 [TBL] [Abstract][Full Text] [Related]
52. The value and limitations of contrast-enhanced ultrasound in detection of prostate cancer. Strazdina A; Krumina G; Sperga M Anticancer Res; 2011 Apr; 31(4):1421-6. PubMed ID: 21508396 [TBL] [Abstract][Full Text] [Related]
53. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. Ellis JH; Tempany C; Sarin MS; Gatsonis C; Rifkin MD; McNeil BJ AJR Am J Roentgenol; 1994 Apr; 162(4):865-72. PubMed ID: 8141009 [TBL] [Abstract][Full Text] [Related]
54. Is preoperative transrectal ultrasonography of value in localised prostatic carcinoma? A blind comparative study between preoperative transrectal ultrasonography and the histopathological radical prostatectomy specimen. Vijverberg PL; Giessen MC; Kurth KH; Dabhoiwala NF; de Reijke TM; van den Tweel JG Eur J Surg Oncol; 1992 Oct; 18(5):449-55. PubMed ID: 1426295 [TBL] [Abstract][Full Text] [Related]
55. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633 [TBL] [Abstract][Full Text] [Related]
56. [Method of the connection HMRS and TRUS images--improvement of effectiveness transrectal core biopsy of the prostate]. Lipczyński W Przegl Lek; 2012; 69(5):176-80. PubMed ID: 23050412 [TBL] [Abstract][Full Text] [Related]